Skip to main content
SpringerLink
Log in

Diagnostic value of alpha-l-fucosidase for hepatocellular carcinoma: a meta-analysis

  • Review
  • Published:
Tumor Biology

Abstract

Alpha-fetoprotein (AFP) is the primary marker for detecting hepatocellular carcinoma (HCC) and has been used widely in the clinic, but AFP is a biomarker characterized by poor sensitivity and specificity. Alpha-l-fucosidase (AFU) has been proposed as a tumor marker for diagnosis of HCC in many studies. However, conclusions of its diagnostic value are inconsistent. The current review aimed to evaluate the diagnostic value of AFU for HCC. After systematic review of 12 related studies, sensitivity, specificity, and diagnostic odds ratio (DOR) were pooled using random-effect models. Summary receiver operating characteristic (sROC) curve analysis was used to summarize the overall test performance. The pooled sensitivity for AFU was 0.72 (95 % confidence interval (CI) 0.69–0.76), while the pooled specificity was 0.78 (95 % CI 0.74–0.81). DOR was 10.26 (95 % CI 5.99–17.59), and the area under the curve (AUC) was 0.8125. AFU had great value for the diagnosis of HCC as a serum marker.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  CAS  PubMed  Google Scholar 

  2. Gish RG. Hepatocellular carcinoma: overcoming challenges in disease management. Clin Gastroenterol Hepatol. 2006;4(3):252–61.

    Article  PubMed  Google Scholar 

  3. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–73.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 \ 1):S35–50.

    Article  PubMed  Google Scholar 

  5. Bertino G, Ardiri A, Malaguarner M, et al. Hepatocellualar carcinoma serum markers. Semin Oncol. 2012;39(4):410–33.

    Article  CAS  PubMed  Google Scholar 

  6. Masuzaki R, Karp SJ, Omata M. New serum markers of hepatocellular carcinoma. Semin Oncol. 2012;39(4):434–9.

    Article  CAS  PubMed  Google Scholar 

  7. Ba MC, Long H, Tang YQ, Cui SZ. GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review. Int J Clin Exp Pathol. 2012;5(9):874–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2010;16(4):418–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol. 2006;12(8):1175–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;10:3–25.

    Google Scholar 

  11. Whiting PF, Rutjes AW, Westwood ME. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.

    Article  PubMed  Google Scholar 

  12. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chen K, Zhang H, Zhang LN, et al. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma. World J Gastroenterol. 2013;19(20):3143–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang JJ, Cao EH. Rapid kinetic rate assay of the serum alpha-l-fucosidase in patients with hepatocellular carcinoma by using a novel substrate. Clin Chim Acta. 2004;347(1–2):103–9.

    Article  CAS  PubMed  Google Scholar 

  15. Ishizuka H, Nakayama T, Matsuoka S, et al. Prediction of the development of hepato-cellular-carcinoma in patients with liver cirrhosis by the serial determinations of serum alpha-l-fucosidase activity. Intern Med. 1999;38(12):927–31.

    Article  CAS  PubMed  Google Scholar 

  16. Giardina MG, Matarazzo M, Morante R, et al. Serum alpha-l-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis. Cancer. 1998;83(12):2468–74.

    Article  CAS  PubMed  Google Scholar 

  17. Hutchinson WL, Du MQ, Johnson PJ, Williams R. Fucosyltransferases: differential plasma and tissue alterations inhepatocellular carcinoma and cirrhosis. Hepatol. 1991;13(4):683–8.

  18. Zheng T, Ren ZY. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma. Chin Med J (Engl). 1990;103(9):729–34.

    CAS  Google Scholar 

  19. Yamamoto K, Yanagita T, Watanabe N, et al. The clinical significance of serum alpha-l-fucosidase assay in hepatocellular carcinoma. Fukuoka Igaku Zasshi. 1988;79(6):463–8.

    CAS  PubMed  Google Scholar 

  20. Deugnier Y, David V, Brissot P, et al. Serum alpha-l-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma? Hepatology. 1984;4(5):889–92.

    Article  CAS  PubMed  Google Scholar 

  21. Bukofzer S, Stass PM, Kew MC, et al. Alpha-l-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks. Br J Cancer. 1989;59(3):417–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. El-Houseini ME, Mohammed MS, Elshemey WM, et al. Enhanced detection of hepatocellular carcinoma. Cancer Control. 2005;12(4):248–53.

    PubMed  Google Scholar 

  23. El-Houseini ME. Serum alpha-l-fucosidase enzyme activity as a marker for hepatocellular carcinoma: comparison with AFU using ROC analysis. J Egyptian Nat Canc Inst. 2001;13:277–83.

    Google Scholar 

  24. El-Tayeh SF, Hussein TD, El-Houseini ME, et al. Serological biomarkers of hepatocellular carcinoma in Egyptian patients. Dis Markers. 2012;32(4):255–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Fawzy Montaser M, Amin Sakr M, Omar KM. Alpha-l-fucosidase as a tumour marker of hepatocellular carcinoma. Arab J Gastroenterol. 2012;13(1):9–13.

    Article  CAS  PubMed  Google Scholar 

  26. Giardina MG, Matarazzo M, Varriale A, et al. Serum alpha-l-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma. Cancer. 1992;70(5):1044–8.

    Article  CAS  PubMed  Google Scholar 

  27. Hutchinson WL, Johnson PJ, Du MQ, et al. Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma. Clin Sci (Lond). 1991;81(2):177–82.

  28. Marotta F, Chui DH, Safran P, Zhang SC. Serum alpha-l-fucosidase. A more sensitive marker for hepatocellular carcinoma? Dig Dis Sci. 1991;36(7):993–7.

    Article  CAS  PubMed  Google Scholar 

  29. Shao Y. Union examination of AFP, AFU, AFPL3 and γ-GT in early diagnosis of primary liver cancer. Academic Journal of Xi’an Jiaotong University. 2009;21(3).

  30. Takahashi H, Saibara T, Iwamura S. Serum a-l-fucosidase activity and tumor size in hepatocellular carcinoma. Hepatology. 1994;19(6):1414–7.

    CAS  PubMed  Google Scholar 

  31. Tangkijvanich P, Tosukhowong P, Bunyongyod P, et al. Alpha-l-fucosidase as a serum marker of hepatocellular carcinoma in Thailand. Southeast Asian J Trop Med Public Health. 1999;30(1):110–4.

    CAS  PubMed  Google Scholar 

  32. Zhu J, Jiang F, Ni HB, et al. Combined analysis of serum gamma-glutamyl transferase isoenzyme II, alpha-l-fucosidase and alpha-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma. Exp Ther Med. 2013;5(1):89–94.

    CAS  PubMed  Google Scholar 

  33. Troost J, van der Heijden MC, Staal GE. Characterisation of alpha-l-fucosidase from two different families with fucosidosis. Clin Chim Acta. 1976;73(2):329–46.

    Article  CAS  PubMed  Google Scholar 

  34. Zielke K, Okada S, O’Brien JS. Fucosidosis: diagnosis by serum assay of a-Lfucosidase. J Lab Clin Med. 1972;79(1):164–9.

    CAS  PubMed  Google Scholar 

  35. Van Hoof F, Hers HG. The abnormalities of lysosomal enzymes in mucopolysaccharidoses. Eur J Biochem. 1968;7(1):34–44.

    Article  PubMed  Google Scholar 

  36. Elshemey WM, Desouky OS, Mohammed MS. Characterization of cirrhosis and hepatocellular carcinoma using low-angle x-ray scattering signatures of serum. Phys Med Biol. 2003;48(17):N239–46.

    Article  PubMed  Google Scholar 

  37. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol. 2007;4(7):424–32.

    Article  CAS  PubMed  Google Scholar 

  38. Jones CM, Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg. 2005;79(1):16–20.

    Article  PubMed  Google Scholar 

  39. Yi X, Yu S, Bao Y. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis. Clin Chim Acta. 2013;425C:212–20.

    Article  Google Scholar 

Download references

Conflict of interest

None

Author information

Authors and Affiliations

  1. Department of Surgery of Bone Tumour, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, 830000, China

    Yuling Gan, Qiuzhen Liang & Xinghua Song

Authors
  1. Yuling Gan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiuzhen Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinghua Song
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xinghua Song.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 24 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gan, Y., Liang, Q. & Song, X. Diagnostic value of alpha-l-fucosidase for hepatocellular carcinoma: a meta-analysis. Tumor Biol. 35, 3953–3960 (2014). https://doi.org/10.1007/s13277-013-1563-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1563-8

Keywords

Search

Navigation